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Introduction

Reboxetine (RBX), (RS)-2-[(RS)-a-(2-ethoxyphenoxy) benzyl] morpholinemethanesulphonate (
is a novel selective noradrenaline reuptake inhibitor with proven efficacy in a wide range of patients with major depressive disorder. RBX is a mixture of (R,R) and (S,S) enantiomers and has potent antidepressant activity, low affinity for alpha-adrenergic and muscarinic receptors, and low toxicity in animals [1] . Its selectivity, limited to noradrenaline reuptake inhibition, appears to result in a favorable clinical profile [2] . Extensive clinical data indicate that reboxetine is a clinically efficacious and well-tolerated antidepressant [3] .
Various analytical techniques for racemic RBX determination in plasma include high performance liquid chromatography (HPLC) with ultra-violet [4] [5] [6] , fluorescence [5] or mass spectrometric detection [7, 8] . Capillary electrophoresis and derivative spectrophotometry have been used to determine RBX in tablets [9] . Except for HPLC-MS all these methods require cumbersome and time-consuming preliminary extractions. Spectrophotometry is not suitable for RBX determination in biological samples. Column-switching techniques and more sophisticated instruments like HPLC-MS impose extra costs in routine analysis. There has been no electrochemical study of RBX, nor has there been a voltammetric RBX analysis for tablets or biological samples.
Electrochemical techniques offer high sensitivity and do not require large sample volumes. They have the advantages of simplicity, low cost, and relatively short analysis time. Different electroactive species are oxidized and/or reduced at different potentials giving selectivity, but many substances may interfere if their peak potentials are close or they are major components.
This study describes RBX electrochemical reduction at the hanging mercury drop electrode (HMDE), chosen for its wide cathodic window. Oxidation is done at the glassy carbon electrode (GCE), since mercury oxidation limits the HMDE anodic window. A tentative oxidation reaction mechanism is proposed. Validated new simple
Central European Journal of Chemistry
Voltammetric methods of reboxetine analysis and the mechanism of its electrode reactions and rapid methods for direct RBX determination in tablets, human plasma, and urine samples are reported. Using the reduction peak at the HMDE square-wave voltammetry (SWV), differential pulse voltammetry (DPV), square-wave cathodic adsorptive stripping voltammetry (SWCAdSV), and differential pulse cathodic adsorptive stripping voltammetry (DPCAdSV) are described. Square-wave voltammetry (SWV) assay is also described using the oxidation peak at the GCE.
Experimental procedure
Apparatus
Voltammetric measurements at the HMDE or GCE were carried out using CH Instrument (CHI 760) or BAS 100W (Bio Analytical System, USA) electrochemical analyzers, respectively. The three electrode cell used in all experiments contained an HMDE (BAS CGME 1108) or glassy carbon electrode (BAS; MF 2012) as working electrode, platinum wire auxiliary electrode (BAS MW-1034) and an Ag/AgCl (3.0 M KCl) reference (MF-2052 RE-5B). Before each experiment the GCE was manually polished with 0.01 µm aluminum oxide slurry on a smooth pad (BAS velvet polishing pad) and thoroughly rinsed with double-distilled water.
pH was measured with a Thermo Orion model 720A pH meter and an Orion combination electrode (Thermo Fisher Scientific model 912600) calibrated with pH 4.13 and pH 8.20 buffers. Double-distilled deionized water was supplied by a Human Power I+ Ultra Pure Water System (ELGA PURELAB Option-S). All measurements were performed at room temperature.
Reagents and solutions
RBX was kindly supplied by Pfizer Inc. (USA) as the methanesulphonic acid salt and Edronax ® tablets (5.2 mg RBX per tablet) were purchased locally. All chemicals were reagent grade.
Stock RBX solutions (1×10 −3 M) were prepared in methanol and kept in the dark in a refrigerator. RBX working solutions were prepared by dilution of the stock solution with supporting electrolyte and used within 24 h to avoid decomposition. Three different supporting electrolytes were prepared in double-distilled deionized water: phosphate buffer (0.2 M; pH 3.00 -7.99), acetate buffer (0.2 M; pH 3.50 -5.50), and Britton-Robinson buffer (BR) (0.04 M, pH 2.00-12.00).
Procedure
A known volume of RBX solution was added to 10.0 mL supporting electrolyte and purified nitrogen was passed through the cell for 5 min to remove dissolved oxygen. For adsorptive stripping measurements, the accumulation potential was applied to the electrode for the accumulation time while the solution was stirred at 400 rpm. The stirrer was stopped and 5 s was allowed for the solution to become quiescent. Voltammograms using different waveforms were then recorded by scanning the potential versus the Ag/AgCl reference toward the positive direction at the GCE for oxidations, and toward the negative direction at the HMDE for reductions. The peak current was measured using the software's tangent line determination.
Preparation of Edronax
® tablets
Edronax
® tablets contain 5.2 mg RBX per tablet. Ten tablets were accurately weighed, crushed to a homogeneous fine powder in a mortar and mixed. A powder sample equivalent to one tablet was weighed and transferred to a 25 mL volumetric flask flask containing about 10.0 mL of methanol and the contents sonicated for 10 min. After standing at room temperature the flask was filled to the mark with methanol. A sample of the clear supernatant was withdrawn and quantitatively diluted with supporting electrolyte for voltammetry. Quantitation in all methods was from the equations describing the calibration curve.
Analysis of human serum
Drug-free human serum from healthy volunteers was stored frozen. After gentle thawing the mixture was spiked to 1×10 −4 M RBX, vortexed for 25 s and centrifuged for 10 min at 5000×g. Acetonitrile was added to the supernatant (2.0 mL) to precipitate serum proteins. An aliquot of this solution was added to the voltammetric cell containing 10.0 mL of supporting electrolyte giving 0.2 to 10.0 µg of RBX.
Analysis of urine
Aliquots of drug-free urine (2.0 mL) were spiked to 1×10 −4 M with RBX in BR and mixed well using a vortex mixer. This solution (100 to 1000 μL) was added to the cell containing 10.0 mL of BR and voltammograms were recorded. 
Results and discussion
The electrochemistry, diffusion, and adsorption of RBX were studied using cyclic voltammetry (CV), and squarewave voltammetry (SWV). Reduction was studied at the HMDE and oxidation was characterized in detail at the GCE.
Electrochemical behavior of RBX at the HMDE and GCE
In CV at the HMDE a single well-defined reduction peak between −1.4 V and −1.5 V (pH 11.0) and an oxidation peak at the GCE at about 1.1 V (pH 7.0) were observed ( Fig. 2) . No peaks were observed using only supporting electrolyte. Anodic and cathodic peak currents increase with increasing RBX concentration ( Fig. 2 insets) implying that the peaks are caused by RBX. As seen in Fig. 2a , the anodic peak observed during a reverse scan at the HMDE suggests that RBX reduction is reversible.
On the other hand, there is no cathodic peak in the reverse scan at the GCE (Fig. 2b) suggesting that RBX oxidation is irreversible. According to the Randles-Sevick equation, in a diffusion-controlled process i p (peak current) is proportional to v 1/2 (v = scan rate), and for an adsorptive process i p is proportional to v. The cathodic peak current (i p,c ) at the HMDE and anodic peak current (i p,a ) at the GCE were investigated for 0.9 mM RBX from 0.005 to 1.0 V s -1 . As shown in Fig. 3a and inset A both anodic and cathodic peak currents at the HMDE changed linearly with scan rate. The peak cathodic current obeys i p,c (μA) = 1.7 v (V/s) + 0.03 (R 2 = 0.9971) and the anodic peak current obtained from a reverse scan of the cathodic peak obeys i p,a (μA) = −1.3 v (V/s) − 0.1 (R 2 = 0.9945). This demonstrates the adsorptive nature of the cathodic and anodic peaks. However, the oxidation current of RBX at the GCE is not linear in scan rate ( Fig. 3b inset A) .
A log -log plot of cathodic peak current vs. scan rate at the HMDE gave a straight line with a slope of 0.9 (R 2 =0.9991) (Fig. 3a , inset C). For anodic oxidation at the GCE this slope was 0.6 (R 2 =0.9812) (Fig. 3b, inset C) . The slope for reduction at the HMDE is very close to the theoretical value of 1.0 for adsorbed species, which shows that RBX reduction at the HMDE is controlled mainly by adsorption. This result is supported by the nonlinear relationship in Fig. 3a , inset B.
As noted above, diffusion control of the oxidation peak at the GCE was identified by the linearity and slope of 0.6 in a plot of log i p vs. log v, in agreement with the theoretical value of 0.5. The linearity of the i p vs. v 1/2 plot (R 2 = 0.9823) supports this conclusion (Fig. 3b,  inset B) .
For an ideally reversible electrochemical mechanism, the anodic peak current to cathodic peak current ratio should be unity, and the peak potential is independent of scan rate. At the HMDE the ratio (i p,a /i p,c ) was 1.0 for 0.005 to 1.0 V s -1 scan rates. However, a small change in cathodic peak potential was recorded with increasing scan rate and concentration (Figs. 2a, 3a) .
There is no reduction peak observed in the reverse scan at the GCE and the peak potential linearly shifted to more positive values with increasing rate (Fig. 3b,  inset D) confirming the irreversible RBX oxidation at the GCE. For an irreversible oxidation the relationship between the peak potential (E p,a ) and log v is linear with slope equal to RT/nαF where α is charge transfer coefficient and n is the number of electrons in the rate determining step [10] . For RBX oxidation at the GCE, the E p,a vs. log v plot was linear, given by E p (V) = 0.1 log v + 1.1 (R 2 = 0.9851)with nα equal to 0.59. Moreover, for an irreversible electrochemical reaction, the peak half-width (W 1/2 ) is 62.4/nα [11] . For RBX the cyclic voltammogram peak half-width was approximately 98 mV, giving nα of 0.63.
The voltammogram characteristics were strongly dependent on pH. Cyclic and square-wave voltammograms of RBX in different supporting electrolyte pH (2.0-11.0) are shown in Fig. 4 . Two oxidation/reduction couples were observed in cyclic voltammograms at pH 10.0 (Fig. 4a) . At pH > 10.0 only one oxidation/reduction couple was observed because the second couple probably occurs at a more cathodic potential than hydrogen evolution at the HMDE. The cathodic peak shifted toward a more negative potential (Fig. 4a) at the HMDE and the anodic peak potential shifted toward less positive potential (Fig. 4b ) at the GCE with increasing pH, indicating hydrogen ion involvement in both electrode processes. Both cathodic (Fig. 4a , inset) and anodic (Fig. 4b, inset) peak potentials have linear relationships with pH in two regions. For cathodic and anodic peaks the lines intercept at pH around 8.3 and 8.1 respectively. These values match the literature pK a (8.4) of RBX [12] . The Ep -pH relationships for the cathodic peak for pH 8.0-11.0, and for the anodic peak for pH 4.0-8.0 are: Anodic and cathodic peak potential vs. pH plots indicate that for both oxidation and reduction of RBX two reduced forms are present. At pH lower and higher than the pK a the slopes for reduction at the HMDE were approximately 0 and −130 mV. Those for oxidation at the GCE were approximately 65 and 0 mV. This indicates that protons are not involved in the rate-determining step at pH < 8.4 for the reduction, nor at pH > 8.4 for the oxidation. According to the Nernst equation E p = Eº− 2.303(RT∂/nF) pH (where ∂ is the number of hydrogen ions involved and n the number of electrons transferred at the electrode). The slopes of the E p -pH plots [13] at pH > 8.4 and pH < 8.4 give ∂/n of 3/2 for the cathodic peak (HMDE) and 1.1 for the anodic peak (GCE). The number of electrons transferred calculated from the CV results according to the literature method [14] was 2.0 ± 0.1.
An oxidation mechanism for RBX at the GCE can be proposed by combining the results obtained here with the literature [15] . Scheme 1 shows RBX oxidation at the GCE by one-electron transfer from the amine and its deprotonation at pH < 8.4. On the other hand, oxidation of RBX at pH > 8.4 may occur through a one-electron transfer from the aromatic nucleus, yielding an unstable cation-radical [15] .
For RBX reduction at the HMDE (at pH > 8.4) protonation can take place at any of the oxygen atoms before electron transfer. However, further studies are necessary to propose a reduction mechanism for the pH dependent and independent regions (Fig. 4a, inset) .
Voltammetric determination of RBX
Peak currents from RBX reduction at the HMDE and oxidation at the GCE were measured by SWV and DPV. Suggested by the adsorptive behavior of RBX, more sensitive cathodic and anodic adsorptive stripping techniques were also applied. Good results were obtained for SWV, DPV, SWCAdSV, and DPCAdSV at the HMDE and for SWV at the GCE.
Adsorptive stripping techniques were examined at both the HMDE and GCE, and the effects of accumulation time (t acc ) and accumulation potential (E acc ) on the cathodic and anodic peak currents in 0.04 μM RBX were investigated. However, after stripping parameter optimization for the GCE the lower limit of the linear range for the anodic adsorptive stripping techniques was very close to the value obtained without stripping, especially with SWV. Therefore, further stripping studies at the GCE were not performed.
Voltammetric stripping methods were examined at the HMDE. The optimum accumulation potentials and accumulation times were −0.8 V, 45 s for SWCAdSV and −0.4 V, 60 s for DPCAdSV.
Using these conditions, the voltammetric procedures for RBX determination were examined. Peak currents were measured as a function of RBX concentration; five serial measurements for each RBX concentration were averaged. Calibration plots are shown in Fig. 5 . The linearity was checked by analyzing standard solutions at more than 10 different concentrations for each method. The calibration characteristics are summarized in Table 1 .
Validation of the proposed methods for RBX determination was performed by evaluation of the linearity, limit of detection (LOD), limit of quantification (LOQ), repeatability (within-day), reproducibility (between-day), specificity, recovery, precision and accuracy. The good linearity of the calibration graphs and the negligible scatter of the experimental points are clearly evident from the correlation coefficients and standard deviations (Table 1 ) for all methods. As shown in Table 1 , SWV using the HMDE is more sensitive than DPV using HMDE or SWV using the GCE. Based on the LOD and LOQ, the adsorptive stripping voltammetric methods' working ranges are narrower than the other methods. Thus, SWV and DPV methods are suitable for drug development and quality control. Stripping methods are suitable for biological samples containing trace RBX. Scheme 1. Proposed oxidation mechanism of RBX at the GCE. 
RBX assay in tablets, human serum and urine
To evaluate the methods' applicability to pharmaceutical preparations and biological samples, RBX was determined in Edronax® tablets, spiked human serum and urine samples by direct calibration. When a portion of the tablet solution was added to BR at optimum pH, a cathodic peak around −1.2 V at the HMDE (Fig. 6A) and an anodic peak around 1.0 V at the GCE (Fig. 6B) were recorded. The results are in Table 2 .
As can be seen in Table 2 , the mean results for all techniques at both electrodes were very close to the declared value of 5.2 mg RBX per tablet. Standard additions recoveries provie further validation (Table 2) . Mean recoveries for DPV, SWV, SWCAdSV, and DPCAdSV at the HMDE, as well as SWV at the GCE are 97.7-100.2 %. RBX in pharmaceuticals can be determined using these methods without interference from other substances in the tablet.
Recoveries from human serum and urine spiked in the therapeutic range or amounts present in human urine [16] [17] [18] were examined. Based on the linear working ranges, stripping methods (SWCAdSV and DPCAdSV) were tested for serum analysis and only DPCAdSV was tested for urine analysis.
For RBX-free urine no voltammetric signal was observed (Fig. 7) indicating that there is no interference from compounds present in human urine. DPCAdSV was tested for quantitative RBX determination (Fig. 7) . Recoveries were 98.6 -100.4% and differences between the spiked and calculated concentrations are insignificant at the 95% confidence level. Precision is good (RSD < 7.7%; Table 3 ).
SWCAdSV and DPCAdSV measurements on serum samples containing RBX gave no reduction peak. This may be because about 98% of RBX is bound to plasma protein [18] . Either protein-bound RBX precipitates when acetonitrile is added or the proteinbound RBX is electrochemically inactive. To examine these possibilities, proteins were precipitated from RBX-free serum. These solutions were spiked with RBX, voltammograms recorded, and recoveries found to be 98.5%. Bovine serum albumin (BSA) is similar to human serum albumin [19] [20] [21] [22] [23] . Increasing amounts of BSA were added to a cell containing a known amount of RBX and SWCAdSV and DPCAdSV measurements were recorded. The RBX peak current decreases with increasing BSA concentration (Fig. 8 ). Due to strong RBX-protein binding quantitative RBX determinations cannot be performed on serum.
Conclusions
Electrochemical reduction of RBX at the HMDE and its oxidation at the GGE over a broad pH range (2.0-11.0) is first reported. An oxidation mechanism (Scheme 1) was proposed but due to the complex behavior of RBX at the HMDE, a reduction mechanism could not be suggested. Reduction of RBX at the HMDE involves adsorption and a three proton/two electron transfer at pH > 8.4. Oxidation of RBX at the GCE involves diffusion and a one proton/one electron transfer at pH < 8.4, or a one electron transfer at pH > 8.4. Using the linear relationship between peak current and drug concentration, validated voltammetric (SWV and DPV) procedures were described for quantitative RBX determination in tablets. In biological samples stripping methods are suitable. SWV methods are more sensitive than DPV methods. Using SWCAdSV and DPCAdSV spontaneous RBX-protein binding was observed 
